It's not a complicated strategy, but you may need to plan ahead. One big misconception a lot of people have about retirement is that they won't have to pay a lot of taxes. In reality, there are many different income sources that the IRS could get a piece of. For example, dividends you receive in a regular brokerage will be taxed, and you'll face capital gains taxes if you sell investments at a pro...
It's not a complicated strategy, but you may need to plan ahead. One big misconception a lot of people have about retirement is that they won't have to pay a lot of taxes. In reality, there are many different income sources that the IRS could get a piece of. For example, dividends you receive in a regular brokerage will be taxed, and you'll face capital gains taxes if you sell investments at a profit. And if you have your retirement savings in a traditional IRA or 401(k) plan, those withdrawals will be taxable as well. Even your Social Security benefits may be taxable, depending on your situation. The good news is that there's an easy way to set yourself up with tax-free income in retirement. But in some cases, you may need to plan for it ahead of time. Rely on a Roth retirement plan Roth retirement plans aren't funded on a pre-tax basis like traditional retirement accounts. But they offer the benefit of tax-free gains and withdrawals. Here's the catch, though. It's not a given that you'll be able to fund a Roth retirement plan directly. If you income is too high, you're barred from contributing to a Roth IRA. And if your company doesn't offer a Roth 401(k), or a retirement plan at all, for that matter, then that, too, is off the table. You can, in situations like these, contribute to a traditional retirement account and do a Roth conversion so you're able to withdraw from your savings later in life without having to pay taxes on that money. But a Roth conversion is something you need to time very carefully. Be strategic with your Roth conversion When you do a Roth conversion, the money you move over counts as taxable income that year. That could have huge implications. For one thing, a Roth conversion could propel you into a higher bracket. But it could also impact your finances down the line. If you do a Roth conversion this year with plans to sign up for Medicare in two years, you could face surcharges on your Part B premiums due to your 2026 income reaching a ce...
hapabapa/iStock Editorial via Getty Images British contract manufacturer OXB ( OXBDF ) on Wednesday announced a multi-year commercial supply agreement with Bristol-Myers Squibb ( BMY ) in support of the pharma giant’s CAR-T therapy programs. OXB ( OXBDF ) will manufacture and supply lentiviral vectors for Bristol-Myers’ ( BMY ) CAR-T programs using its facilities in Oxford, UK, and Durham, NC, as ...
hapabapa/iStock Editorial via Getty Images British contract manufacturer OXB ( OXBDF ) on Wednesday announced a multi-year commercial supply agreement with Bristol-Myers Squibb ( BMY ) in support of the pharma giant’s CAR-T therapy programs. OXB ( OXBDF ) will manufacture and supply lentiviral vectors for Bristol-Myers’ ( BMY ) CAR-T programs using its facilities in Oxford, UK, and Durham, NC, as part of the deal, which has an initial five-year term with an option to extend. Under the renewed deal, OXB ( OXBDF ), formerly known as Oxford Biomedica, will start commercial production of lentiviral vectors in 2026, subject to regulatory clearance of the related CAR-T products. The partnership builds on the companies’ existing collaboration signed in March 2020, the Oxford-based firm said, adding that it will bring “meaningful multi-year revenue” and back the company’s current medium-term financial guidance. More on Bristol-Myers Squibb Bristol Myers Squibb: The Rerating Was Fast - The Proof Will Be Slow (Rating Downgrade) Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion 44th Annual J.P. Morgan Healthcare Conference FDA launches PreCheck program to assist in building pharma plants Earnings week ahead: AMZN, GOOG, PLTR, AMD, PFE, DIS, PYPL, ABBV, QCOM, SMCI, MRK, PEP, UBER, PM, and more
Evercore press release ( EVR ): Q4 Non-GAAP EPS of $5.13 beats by $1.08 . Revenue of $1.30B (+32.6% Y/Y) beats by $180M . Record Fourth Quarter and Full Year Net Revenues were $1.3 billion and $3.9 billion, respectively, on both a U.S. GAAP and an Adjusted basis. Fourth Quarter and Full Year Net Revenues increased 32% and 29%, respectively, on both a U.S. GAAP and an Adjusted basis versus 2024 Mor...
Evercore press release ( EVR ): Q4 Non-GAAP EPS of $5.13 beats by $1.08 . Revenue of $1.30B (+32.6% Y/Y) beats by $180M . Record Fourth Quarter and Full Year Net Revenues were $1.3 billion and $3.9 billion, respectively, on both a U.S. GAAP and an Adjusted basis. Fourth Quarter and Full Year Net Revenues increased 32% and 29%, respectively, on both a U.S. GAAP and an Adjusted basis versus 2024 More on Evercore Evercore: Large Ticket Deals Still Going Strong Into Q4 Evercore Inc. (EVR) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript Evercore Inc. 2025 Q3 - Results - Earnings Call Presentation Evercore Q4 2025 Earnings Preview Lazard, Evercore get new Buys, Piper Sandler lands at Underperform: BofA
Brookfield Asset Management Ltd. press release ( BAM ): Q4 Non-GAAP EPS of $0.47 beats by $0.03 . Revenue of $1.39B (+31.1% Y/Y) misses by $40M . Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025 Quarterly Fee-Related Earnings of $867 Million , Up 28% Year-Over-Year Quarterly Distributable Earnings of $767 Million, Up 18% Year-Over-Year. The Board of Directors approved t...
Brookfield Asset Management Ltd. press release ( BAM ): Q4 Non-GAAP EPS of $0.47 beats by $0.03 . Revenue of $1.39B (+31.1% Y/Y) misses by $40M . Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025 Quarterly Fee-Related Earnings of $867 Million , Up 28% Year-Over-Year Quarterly Distributable Earnings of $767 Million, Up 18% Year-Over-Year. The Board of Directors approved the appointment of Connor Teskey as Chief Executive Officer of BAM. Bruce Flatt will continue in his role as Chair of the Board, in addition to his role as Chief Executive Officer of Brookfield Corporation. The board of directors of BAM declared a quarterly dividend of $0.5025 per share, representing a 15% increase, payable on March 31, 2026, to shareholders of record as of the close of business on February 27, 2026. More on Brookfield Asset Management Ltd. Brookfield Asset Management: Offers Good Growth Potential Brookfield Asset Management: Buy This Dividend Growth Monster Now Brookfield Asset Management Ltd. (BAM:CA) Presents at Goldman Sachs 2025 U.S. Financial Services Conference Transcript Brookfield Asset Management to renew normal course issuer bid Brookfield, Qatar partner on $20 billion AI investment venture
Eli Lilly press release ( LLY ): Q4 Non-GAAP EPS of $7.54 beats by $0.61 . Revenue of $19.29B (+42.6% Y/Y) beats by $1.35B . 2026 guidance issued with revenue in the range of $80 billion to $83 billion and non-GAAP EPS in the range of $33.50 to $35.00. FY26 revenue consensus of $77.56B, EPS consensus of $33.30 Shares +5% PM. More on Eli Lilly Eli Lilly: Obesity Pricing For Access Tradeoff A Net Po...
Eli Lilly press release ( LLY ): Q4 Non-GAAP EPS of $7.54 beats by $0.61 . Revenue of $19.29B (+42.6% Y/Y) beats by $1.35B . 2026 guidance issued with revenue in the range of $80 billion to $83 billion and non-GAAP EPS in the range of $33.50 to $35.00. FY26 revenue consensus of $77.56B, EPS consensus of $33.30 Shares +5% PM. More on Eli Lilly Eli Lilly: Obesity Pricing For Access Tradeoff A Net Positive Eli Lilly: Breakout To New Highs Sends A Clear Warning Shot Eli Lilly: Buy Ahead Of Its Earnings Day (Preview) Novo Nordisk falls after 2025 results, dragging Lilly (update) Eli Lilly Q4 Preview: Obesity drug momentum, Medicare tailwinds lift analysts' optimism
Advertisement Expanded portfolio roadmap tied to AI-driven connectivity needs Astera Labs (ALAB) is expanding its portfolio roadmap to cover increased radix, platform-specific protocols, in-network computing, Hypercast technology, and optical connectivity, all shaped by feedback from hyperscalers. Astera Labs’ latest connectivity roadmap lands after a mixed stretch for the stock, with a 1-day shar...
Advertisement Expanded portfolio roadmap tied to AI-driven connectivity needs Astera Labs (ALAB) is expanding its portfolio roadmap to cover increased radix, platform-specific protocols, in-network computing, Hypercast technology, and optical connectivity, all shaped by feedback from hyperscalers. Astera Labs’ latest connectivity roadmap lands after a mixed stretch for the stock, with a 1-day share price return of 3.99% to US$158.52 contrasting with weaker recent share price returns. At the same time, the 1-year total shareholder return of 55.82% points to momentum that has built over a longer window. If AI-driven connectivity is on your radar, this could be a useful moment to broaden your watchlist with as potential candidates for your next idea. With revenue of US$723.04 million, net income of US$198.87 million, a 1-year total return of 55.82%, and shares trading at US$158.52 against an average analyst target of US$202.26, is there still a buying opportunity here, or is the market already pricing in future growth? Most Popular Narrative: 20.4% Undervalued At a last close of $158.52 versus a narrative fair value of $199.15, the most followed view prices in a meaningful upside gap that hinges on aggressive AI connectivity buildout assumptions. Strong early engagement with hyperscalers and AI platform providers on open, interoperable standards like UALink (which are still in the early adoption phase with projected ramp in 2027 and beyond) positions Astera Labs to capture the industry's shift toward open, multi-vendor AI Infrastructure 2.0. This ensures exposure to significant long-term market expansion and incrementally larger addressable markets, with the potential to positively influence revenue growth rates and future margin dynamics as adoption progresses. Curious what justifies that kind of upside gap? The narrative leans heavily on rapid revenue compounding, rising margins, and a premium earnings multiple that assumes this AI cycle has a long way to run. Result...
Morris Chang, founder of Taiwan Semiconductor Manufacturing (NYSE:TSM), made his first public appearance in over a year alongside Nvidia CEO Jensen Huang. The two reportedly shared a private dinner, with observers indicating Chang is in good health, mentally sharp and in good spirits. The event has drawn attention because Chang had not appeared publicly throughout 2025, prompting questions about h...
Morris Chang, founder of Taiwan Semiconductor Manufacturing (NYSE:TSM), made his first public appearance in over a year alongside Nvidia CEO Jensen Huang. The two reportedly shared a private dinner, with observers indicating Chang is in good health, mentally sharp and in good spirits. The event has drawn attention because Chang had not appeared publicly throughout 2025, prompting questions about his health and the broader leadership picture at TSMC. The meeting also highlights TSMC's continued close relationship with a major customer in high performance and AI chips. For you as an investor, this is notable because TSMC sits at the center of global chip manufacturing, supplying advanced semiconductors to leading designers across computing and AI. Any uncertainty around its leadership story tends to attract extra scrutiny, especially as chipmakers play a key role in everything from data centers to consumer electronics. Chang's visibly good health and engagement with Nvidia's CEO may reassure investors who had been watching for signs of instability at the company or in its partner network. It also underscores that high level conversations between TSMC and major customers continue, which can be important when you think about capacity planning, technology roadmaps and long term demand for advanced manufacturing services. Stay updated on the most important news stories for by adding it to your or . Alternatively, explore our to discover new perspectives on Taiwan Semiconductor Manufacturing. NYSE:TSM 1-Year Stock Price Chart Advertisement Quick Assessment ⚖️ Price vs Analyst Target : At US$335.75, TSM trades about 18% below the US$409.49 analyst target, so sentiment from the street still skews higher than the current price. : At US$335.75, TSM trades about 18% below the US$409.49 analyst target, so sentiment from the street still skews higher than the current price. ❌ Simply Wall St Valuation : Shares are described as trading 47.2% above estimated fair value, which flags ...
In this article AMD NVDA ORCL Follow your favorite stocks CREATE FREE ACCOUNT Chipmaker Advanced Micro Devices (AMD) dropped 9% in early market premarket trading on Wednesday after its first-quarter forecast fell short of some analyst expectations. AMD reported revenue of $10.27 billion for the fourth quarter that topped LSEG consensus estimates of $9.67 billion on Tuesday. The company said it exp...
In this article AMD NVDA ORCL Follow your favorite stocks CREATE FREE ACCOUNT Chipmaker Advanced Micro Devices (AMD) dropped 9% in early market premarket trading on Wednesday after its first-quarter forecast fell short of some analyst expectations. AMD reported revenue of $10.27 billion for the fourth quarter that topped LSEG consensus estimates of $9.67 billion on Tuesday. The company said it expects $9.8 billion in revenue for the first quarter, plus or minus $300 million, versus expectations of $9.38 billion. But some analysts had predicted the chipmaker would provide stronger guidance for the first-quarter amid an ongoing boom in spending for the processors needed to power AI. AMD, which alongside Nvidia is one of the key makers of AI chips, has seen its stock surge more than 100% in the past year on the back of rising demand. Stock Chart Icon Stock chart icon AMD stock over the past year "First, expectations were pretty sky high," said Susquehanna's Chris Rolland, talking on CNBC's "Closing Bell Overtime." "Secondly, they announced they shipped Chinese revenue in the quarter that was unexpected. This was not in street numbers, so when you account for that, the beat was far less substantial than we would've thought." However, he added, demand for AMD's chips in data centers was still strong and the company was hinting at multi-gigawatt contracts to come in the future. The chipmaker inked a deal with OpenAI in October that could see the startup take a 10% stake in AMD. OpenAI will deploy 6 gigawatts of AMD's Instinct graphics processing units over multiple years beginning with an initial 1-gigawatt rollout of chips in the second half of 2026, the companies said. Oracle also announced in October plans to deploy 50,000 of AMD's AI chips beginning later this year. watch now VIDEO 3:49 03:49 Susquehanna's Chris Rolland talks AMD shares falling on Q4 results Closing Bell: Overtime
AMD stock sinks 12% after earnings. Here's why CNBC AMD posts better than anticipated Q4 earnings and Q1 outlook, but stock falls Yahoo Finance Why AMD’s stock is diving toward its worst day in years after earnings MarketWatch Wall Street Expects Big Things From Advanced Micro Devices’ Earnings Today 24/7 Wall St. AMD predicts weaker first-quarter sales, shares plunge on Nvidia comparisons Reuters...
AMD stock sinks 12% after earnings. Here's why CNBC AMD posts better than anticipated Q4 earnings and Q1 outlook, but stock falls Yahoo Finance Why AMD’s stock is diving toward its worst day in years after earnings MarketWatch Wall Street Expects Big Things From Advanced Micro Devices’ Earnings Today 24/7 Wall St. AMD predicts weaker first-quarter sales, shares plunge on Nvidia comparisons Reuters AMD Outlook Disappoints Investors Seeking Bigger AI Payoff Bloomberg.com Advanced Micro Devices (AMD) Q4 Earnings Today: Options Market Braces for an 8.87% Swing TipRanks AMD Is Being Punished For The Wrong Reasons (Q4 Earnings Review) (NASDAQ:AMD) Seeking Alpha AMD Stock Drops Despite Beat-And-Raise Earnings Report Investor's Business Daily
Cencora ( COR ) declares $0.60/share quarterly dividend , in line with previous. Forward yield 0.66% Payable March 2; for shareholders of record Feb. 13; ex-div Feb. 13. See COR Dividend Scorecard, Yield Chart, & Dividend Growth. More on Cencora Cencora: High-Growth Specialty Services Firm Disguised As A Distributor Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Sl...
Cencora ( COR ) declares $0.60/share quarterly dividend , in line with previous. Forward yield 0.66% Payable March 2; for shareholders of record Feb. 13; ex-div Feb. 13. See COR Dividend Scorecard, Yield Chart, & Dividend Growth. More on Cencora Cencora: High-Growth Specialty Services Firm Disguised As A Distributor Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Cencora Q1 2026 Earnings Preview CD&R, TPG's Covetrus in talks to buy Cencora's vet business - report
US equity futures take a breather from a global rout driven by stocks sensitive to potential disruption from Anthropic's new automation tool. Investors await results from Alphabet and Qualcomm as AMD's AI-fueled outlook disappoints. Shares of Novo Nordisk plunges as the drugmaker forecasts sales to fall as much 13% this year. Iran asks the US to move the scheduled diplomatic talks this week from T...
US equity futures take a breather from a global rout driven by stocks sensitive to potential disruption from Anthropic's new automation tool. Investors await results from Alphabet and Qualcomm as AMD's AI-fueled outlook disappoints. Shares of Novo Nordisk plunges as the drugmaker forecasts sales to fall as much 13% this year. Iran asks the US to move the scheduled diplomatic talks this week from Turkey to Oman and to limit the agenda to Tehran's nuclear program. Stephanie Guild of Robinhood discusses the opportunities in software stocks amid the recent selloff. (Source: Bloomberg)
Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025 Quarterly Fee-Related Earnings of $867 Million, Up 28% Year-Over-Year Quarterly Distributable Earnings of $767 Million, Up 18% Year-Over-Year Connor Teskey Appointed CEO of Brookfield Asset Management NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) (“BAM”), a leading glob...
Fundraised a Record $35 Billion in the Fourth Quarter; $112 Billion for 2025 Quarterly Fee-Related Earnings of $867 Million, Up 28% Year-Over-Year Quarterly Distributable Earnings of $767 Million, Up 18% Year-Over-Year Connor Teskey Appointed CEO of Brookfield Asset Management NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) (“BAM”), a leading global alternative asset manager headquartered in New York with over $1 trillion of assets under management, today announced record financial results for the quarter ended December 31, 2025; the strongest results since listing. The Board of Directors approved the appointment of Connor Teskey as Chief Executive Officer of BAM. Bruce Flatt will continue in his role as Chair of the Board, in addition to his role as Chief Executive Officer of Brookfield Corporation. Bruce Flatt said, “Today’s announcement is the next step in the succession process we started four years ago. This will set up our next generation of leaders who will guide the company in the coming decades. Connor is an exceptional leader who embodies Brookfield’s culture of collaboration, innovation, and discipline. The entire senior management team is thrilled to work with him as he assumes this role and takes BAM to new levels of success.” In discussing results, Connor Teskey said, “2025 was another record year for our business— across each of fundraising, deployment, and monetizations. Our fee-bearing capital grew to over $600 billion, with 22% year-over-year growth in fee-related earnings and 14% growth in distributable earnings. Looking ahead, we will have key flagship strategies in the market and a growing suite of complementary offerings, positioning us to drive sustained growth across multiple channels. This confidence supports our decision to increase our dividend by 15%.” Common Dividend Increase The board of directors of BAM declared a quarterly dividend of $0.5025 per share, representing a 15% increase, pa...